Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Argen-X | Brussels | Healthcare | Biotechnology & Medical Research | €36.57B | -930x | -10.9 | €604.60 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.1% Upside | Upgrade to Pro+ | |
UCB | Brussels | Healthcare | Pharmaceuticals | €35.29B | 147.9x | -5.17 | €186.60 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.3% Upside | Upgrade to Pro+ | |
Tubize-Fin | Brussels | Healthcare | Pharmaceuticals | €6.12B | 69.6x | €137.40 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.1% Upside | Upgrade to Pro+ | ||
Fagron | Brussels | Healthcare | Pharmaceuticals | €1.33B | 17.2x | 1.12 | €18.12 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.1% Upside | Upgrade to Pro+ | |
Ion Beam Applications | Brussels | Healthcare | Healthcare Equipment & Supplies | €390.45M | 49.4x | 0.36 | €13.30 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36.8% Upside | Upgrade to Pro+ | |
Nyxoah | Brussels | Healthcare | Healthcare Equipment & Supplies | €286.52M | -4.4x | 1.62 | €7.80 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ONWARD Medical BV | Brussels | Healthcare | Healthcare Equipment & Supplies | €207.97M | -4.7x | -0.67 | €4.89 | 4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hyloris | Brussels | Healthcare | Pharmaceuticals | €155.12M | -12.6x | 3.21 | €5.30 | -4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AGFA Gevaert | Brussels | Healthcare | Healthcare Equipment & Supplies | €108.37M | -3.2x | -0.04 | €0.70 | 6.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sequana Medical | Brussels | Healthcare | Biotechnology & Medical Research | €33.77M | -0.8x | -0.04 | €0.76 | 9.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Celyad | Brussels | Healthcare | Biotechnology & Medical Research | €28.59M | -3.1x | -0.05 | €0.69 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biocartis Group NV | Brussels | Healthcare | Healthcare Equipment & Supplies | €27.24M | -0.3x | €0.29 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
European Medical Solutions | Brussels | Healthcare | Healthcare Providers & Services | €26.81M | -18x | 0.67 | €0.02 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biosenic | Brussels | Healthcare | Pharmaceuticals | €1.79M | -0.1x | -0.01 | €0.006 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oxurion | Brussels | Healthcare | Biotechnology & Medical Research | €538.69K | €0.27 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Personalized Nursing Services | Brussels | Healthcare | Healthcare Providers & Services | €245K | €0.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |